[go: up one dir, main page]

SE0001151D0 - Method for producing a controlled-release composition - Google Patents

Method for producing a controlled-release composition

Info

Publication number
SE0001151D0
SE0001151D0 SE0001151A SE0001151A SE0001151D0 SE 0001151 D0 SE0001151 D0 SE 0001151D0 SE 0001151 A SE0001151 A SE 0001151A SE 0001151 A SE0001151 A SE 0001151A SE 0001151 D0 SE0001151 D0 SE 0001151D0
Authority
SE
Sweden
Prior art keywords
controlled
producing
pore
release composition
forming agent
Prior art date
Application number
SE0001151A
Other languages
English (en)
Swedish (sv)
Inventor
John Kendrup
Peter Fyhr
Original Assignee
Amarin Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amarin Dev Ab filed Critical Amarin Dev Ab
Priority to SE0001151A priority Critical patent/SE0001151D0/xx
Publication of SE0001151D0 publication Critical patent/SE0001151D0/xx
Priority to PCT/SE2001/000626 priority patent/WO2001074336A1/fr
Priority to EP01914312A priority patent/EP1267842B1/fr
Priority to AT01914312T priority patent/ATE281156T1/de
Priority to JP2001572081A priority patent/JP4963767B2/ja
Priority to EP04025989A priority patent/EP1516616A1/fr
Priority to AU2001239658A priority patent/AU2001239658A1/en
Priority to DE60106889T priority patent/DE60106889T2/de
Priority to US09/819,813 priority patent/US6974591B2/en
Priority to US11/255,073 priority patent/US20060159755A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0001151A 2000-03-31 2000-03-31 Method for producing a controlled-release composition SE0001151D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE0001151A SE0001151D0 (sv) 2000-03-31 2000-03-31 Method for producing a controlled-release composition
PCT/SE2001/000626 WO2001074336A1 (fr) 2000-03-31 2001-03-23 Procede d'elaboration d'une preparation a liberation commandee
EP01914312A EP1267842B1 (fr) 2000-03-31 2001-03-23 Procede d'elaboration d'un comprime a liberation controllee en utilisant un agent porogene dans l'enrobage
AT01914312T ATE281156T1 (de) 2000-03-31 2001-03-23 Verfahren zur herstellung eines tabletts mit kontrollierter freisetzung mit der verwendung von einem porenbildenden agens in der beschichtung
JP2001572081A JP4963767B2 (ja) 2000-03-31 2001-03-23 制御放出性製剤の製法
EP04025989A EP1516616A1 (fr) 2000-03-31 2001-03-23 Une préparation à libération controlée ayant des agents porogènes spécifiques dans l'enrobage
AU2001239658A AU2001239658A1 (en) 2000-03-31 2001-03-23 Method for producing a controlled-release preparation
DE60106889T DE60106889T2 (de) 2000-03-31 2001-03-23 Verfahren zur herstellung eines tabletts mit kontrollierter freisetzung mit der verwendung von einem porenbildenden agens in der beschichtung
US09/819,813 US6974591B2 (en) 2000-03-31 2001-03-29 Method for producing a controlled-release preparation
US11/255,073 US20060159755A1 (en) 2000-03-31 2005-10-19 Method for producing a controlled release preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0001151A SE0001151D0 (sv) 2000-03-31 2000-03-31 Method for producing a controlled-release composition

Publications (1)

Publication Number Publication Date
SE0001151D0 true SE0001151D0 (sv) 2000-03-31

Family

ID=20279094

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0001151A SE0001151D0 (sv) 2000-03-31 2000-03-31 Method for producing a controlled-release composition

Country Status (8)

Country Link
US (2) US6974591B2 (fr)
EP (2) EP1516616A1 (fr)
JP (1) JP4963767B2 (fr)
AT (1) ATE281156T1 (fr)
AU (1) AU2001239658A1 (fr)
DE (1) DE60106889T2 (fr)
SE (1) SE0001151D0 (fr)
WO (1) WO2001074336A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551617B1 (en) * 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
CA2359812C (fr) 2000-11-20 2004-02-10 The Procter & Gamble Company Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
KR20120034211A (ko) * 2002-09-20 2012-04-10 안드렉스 랩스 엘엘씨 약제학적 정제
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
GB0518579D0 (en) * 2005-09-12 2005-10-19 Cr Technologies Llp Controlled delivery creatine formulations and method of using the same
ZA200711123B (en) 2005-06-27 2009-08-26 Biovail Lab Int Srl Modified-release formulations of a bupropion salt
DK2428205T3 (da) 2006-03-16 2012-10-22 Tris Pharma Inc Modificerede formuleringer indeholdende lægemiddel-ionbytterharpikskomplekser
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
DE102006030860A1 (de) * 2006-07-04 2008-01-10 Universität Regensburg Oligomere von Isonitril-Metallkomplexen als Triplett-Emitter für OLED-Anwendungen
CN101766581B (zh) * 2008-12-30 2012-08-15 北京科信必成医药科技发展有限公司 一种群孔释放的盐酸地尔硫卓择时控释片及其制备方法
WO2010134074A1 (fr) 2009-05-19 2010-11-25 Neuroderm Ltd Compositions pour administration continue d'un inhibiteur de la dopa-décarboxylase
AU2010300641B2 (en) 2009-09-30 2016-03-17 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
US8623409B1 (en) 2010-10-20 2014-01-07 Tris Pharma Inc. Clonidine formulation
RS57047B1 (sr) 2010-11-15 2018-05-31 Neuroderm Ltd Neprekidno davanje l dope, inhibitora dopa dekarboksilaze, inhibitora katehol-o-metil transferaze i kompozicije za iste
EP2481411A1 (fr) * 2011-01-27 2012-08-01 Ratiopharm GmbH Formes galéniques orales pour libération modifiée comportant l'inhibiteur de JAK3 tasocitinib
CN104349768B (zh) 2012-06-05 2017-11-07 纽罗德姆有限公司 包含阿朴吗啡和有机酸的组合物及其用途
PL2872121T3 (pl) 2012-07-12 2019-02-28 SpecGx LLC Kompozycje farmaceutyczne o przedłużonym uwalnianiu, zniechęcające do nadużywania
WO2014028610A1 (fr) 2012-08-15 2014-02-20 Tris Pharma, Inc. Comprimé à croquer de méthylphénidate à libération modifiée
WO2015136538A1 (fr) 2014-03-13 2015-09-17 Neuroderm Ltd Compositions d'inhibiteurs de dopa-décarboxylase
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
US12161612B2 (en) 2023-04-14 2024-12-10 Neuroderm, Ltd. Methods and compositions for reducing symptoms of Parkinson's disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USB587055I5 (fr) * 1956-05-24
US4557925A (en) 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
US4629619A (en) * 1984-09-05 1986-12-16 Ab Ferrosan Membrane-coated sustained-release tablets and method
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5376383A (en) 1988-11-21 1994-12-27 Merck & Co., Inc. Method for enhancing the lowering of plasma-cholesterol levels
US5126146A (en) * 1989-10-23 1992-06-30 Merck & Co., Inc. Cellulosic coating
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5324351A (en) * 1992-08-13 1994-06-28 Euroceltique Aqueous dispersions of zein and preparation thereof
US5500227A (en) * 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
US6207190B1 (en) * 1998-08-13 2001-03-27 Chronorx, Llc Dosage forms for the treatment of the chronic glaucomas

Also Published As

Publication number Publication date
ATE281156T1 (de) 2004-11-15
JP2003528910A (ja) 2003-09-30
JP4963767B2 (ja) 2012-06-27
WO2001074336A1 (fr) 2001-10-11
US20010038853A1 (en) 2001-11-08
EP1267842B1 (fr) 2004-11-03
EP1516616A1 (fr) 2005-03-23
AU2001239658A1 (en) 2001-10-15
US6974591B2 (en) 2005-12-13
EP1267842A1 (fr) 2003-01-02
DE60106889D1 (de) 2004-12-09
DE60106889T2 (de) 2006-03-23
US20060159755A1 (en) 2006-07-20

Similar Documents

Publication Publication Date Title
SE0001151D0 (sv) Method for producing a controlled-release composition
ATE355829T1 (de) Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
DE69331948D1 (de) Angenehm schmeckende pharmazeutische zusammensetzungen
DE69933689D1 (de) Verfahren zur herstellung von oralen calcium zusammensetzungen
DK0609961T3 (da) Farmaceutisk præparat med langvarig frigivelse
DE60034565D1 (de) Verfahren zur herstellung eines umhüllten geschmackmaskierten granulats mit sofortiger wirkstofffreisetzung
TNSN91067A1 (fr) Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues.
DE50110049D1 (de) Magnesium-ammonium-phosphat-zemente, deren herstellung und verwendung
IS2403B (is) Fljótleysanleg lyfjaform sem innihalda fiskgelatín
SE9202250D0 (sv) Controlled release morphine preparation
ATE373039T1 (de) Selbstreinigende oberflächen durch hydrophobe strukturen und verfahren zu deren herstellung
ATE380022T1 (de) Multipartikuläre arzneiform, enthaltend mindestens zwei unterschiedlich überzogene pelletformen
ATE286387T1 (de) Clarithromycin enthaltende zubereitung mit verlängerter freisetzung
EE200100161A (et) Segamisest sõltumatud toimeainet aeglustatult vabastavad mitmeosalised ravimvormid ja nende valmistamismeetodid
EP0377517A3 (fr) Forme de dose de théophylline
DE60211769D1 (de) Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen
CY1107559T1 (el) Μικροκοκκοι θειικης μορφινης, μεθοδος παρασκευης και φαρμακευτικα σκευασματα
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
BR9709858A (pt) Composto composição farmacêutica uso do composto e processos para tratamento de doenças do sistema endocrinólogico para fabricação de um medicamento específico para ser usado no tratamento de doenças do sistema endocrinológico e para preparação de um composto
DE69616072D1 (de) Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung
ATE214598T1 (de) Multipartikuläre pharmazeutische form mit gesteuerter und gepulster wirkstoffabgabe und verfahren zu deren herstellung
EP1258254A4 (fr) Preparations a liberation lente contenant un compose physiologiquement actif peu soluble dans l'eau et methode de production et d'utilisation desdites preparations
WO2004066984A3 (fr) Composition pharmaceutique de masquage de gout amelioree et procede de preparation de ladite composition
EA199800553A1 (ru) Порошок вспенивателя и способ его получения
DK1009380T3 (da) Fremgangsmåde til fremstilling af farmaceutiske formuleringer